APO Research
Talk to an analyst

APO RESEARCH · REPORT

Killer Cell Immunoglobulin Like Receptor (KIR)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Killer Cell Immunoglobulin Like Receptor (KIR) Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchKiller Cell Immunoglobulin Like Receptor (KIR) Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Killer Cell Immunoglobulin Like Receptor (KIR) Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Killer Cell Immunoglobulin Like Receptor (KIR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Killer Cell Immunoglobulin Like Receptor (KIR) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Killer Cell Immunoglobulin Like Receptor (KIR) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Killer Cell Immunoglobulin Like Receptor (KIR) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Killer Cell Immunoglobulin Like Receptor (KIR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Killer Cell Immunoglobulin Like Receptor (KIR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Killer Cell Immunoglobulin Like Receptor (KIR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Killer Cell Immunoglobulin Like Receptor (KIR) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Killer Cell Immunoglobulin Like Receptor (KIR) market include R&D Systems, Miltenyi Biotec, BioLegend and Abbexa, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Killer Cell Immunoglobulin Like Receptor (KIR) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Killer Cell Immunoglobulin Like Receptor (KIR) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Killer Cell Immunoglobulin Like Receptor (KIR) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Killer Cell Immunoglobulin Like Receptor (KIR) market.

Killer Cell Immunoglobulin Like Receptor (KIR) Segment by Company

R&D Systems

Miltenyi Biotec

BioLegend

Abbexa

Killer Cell Immunoglobulin Like Receptor (KIR) Segment by Type

2D

3D

Other

Killer Cell Immunoglobulin Like Receptor (KIR) Segment by Application

Medical Science

Experiment

Other

Killer Cell Immunoglobulin Like Receptor (KIR) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Killer Cell Immunoglobulin Like Receptor (KIR) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Killer Cell Immunoglobulin Like Receptor (KIR) key companies, revenue, market share, and recent developments.

3. To split the Killer Cell Immunoglobulin Like Receptor (KIR) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Killer Cell Immunoglobulin Like Receptor (KIR) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Killer Cell Immunoglobulin Like Receptor (KIR) significant trends, drivers, influence factors in global and regions.

6. To analyze Killer Cell Immunoglobulin Like Receptor (KIR) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Killer Cell Immunoglobulin Like Receptor (KIR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Killer Cell Immunoglobulin Like Receptor (KIR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Killer Cell Immunoglobulin Like Receptor (KIR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Killer Cell Immunoglobulin Like Receptor (KIR) industry.

Chapter 3: Detailed analysis of Killer Cell Immunoglobulin Like Receptor (KIR) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Killer Cell Immunoglobulin Like Receptor (KIR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Killer Cell Immunoglobulin Like Receptor (KIR) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Killer Cell Immunoglobulin Like Receptor (KIR) Industry Trends Table 2. Killer Cell Immunoglobulin Like Receptor (KIR) Industry Drivers Table 3. Killer Cell Immunoglobulin Like Receptor (KIR) Industry Opportunities and Challenges Table 4. Killer Cell Immunoglobulin Like Receptor (KIR) Industry Restraints Table 5. Global Killer Cell Immunoglobulin Like Receptor (KIR) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Killer Cell Immunoglobulin Like Receptor (KIR) Revenue Share by Company (2021-2026) Table 7. Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Killer Cell Immunoglobulin Like Receptor (KIR) Key Company Manufacturing Base & Headquarters Table 9. Global Killer Cell Immunoglobulin Like Receptor (KIR) Company, Product Type & Application Table 10. Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Killer Cell Immunoglobulin Like Receptor (KIR) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 2D Table 15. Significant Companies of 3D Table 16. Significant Companies of Other Table 17. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type (2021-2026) Table 21. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medical Science Table 23. Significant Companies of Experiment Table 24. Significant Companies of Other Table 25. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application (2021-2026) Table 29. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application (2027-2032) Table 30. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Region (2021-2026) Table 33. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Region (2027-2032) Table 35. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Market Share by Country (2021-2026) Table 38. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Market Share by Country (2027-2032) Table 40. R&D Systems Company Information Table 41. R&D Systems Business Overview Table 42. R&D Systems Killer Cell Immunoglobulin Like Receptor (KIR) Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. R&D Systems Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio Table 44. R&D Systems Recent Development Table 45. Miltenyi Biotec Company Information Table 46. Miltenyi Biotec Business Overview Table 47. Miltenyi Biotec Killer Cell Immunoglobulin Like Receptor (KIR) Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Miltenyi Biotec Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio Table 49. Miltenyi Biotec Recent Development Table 50. BioLegend Company Information Table 51. BioLegend Business Overview Table 52. BioLegend Killer Cell Immunoglobulin Like Receptor (KIR) Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. BioLegend Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio Table 54. BioLegend Recent Development Table 55. Abbexa Company Information Table 56. Abbexa Business Overview Table 57. Abbexa Killer Cell Immunoglobulin Like Receptor (KIR) Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Abbexa Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio Table 59. Abbexa Recent Development Table 60. Research Programs/Design for This Report Table 61. Authors List of This Report Table 62. Secondary Sources Table 63. Primary Sources List of Figures Figure 1. Killer Cell Immunoglobulin Like Receptor (KIR) Product Image Figure 2. Global Killer Cell Immunoglobulin Like Receptor (KIR) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Killer Cell Immunoglobulin Like Receptor (KIR) Market Size (2021-2032) & (US$ Million) Figure 4. Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 2D Image Figure 8. 3D Image Figure 9. Other Image Figure 10. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type (2021-2032) Figure 13. Medical Science Image Figure 14. Experiment Image Figure 15. Other Image Figure 16. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application (2021-2032) Figure 19. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032) & (US$ Million) Figure 22. North America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032) & (US$ Million) Figure 28. South America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • 2D
  • 3D
  • Other
Applications
  • Medical Science
  • Experiment
  • Other
Companies covered
  • R&D Systems
  • Miltenyi Biotec
  • BioLegend
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Killer Cell Immunoglobulin Like Receptor (KIR) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Killer Cell Immunoglobulin Like Receptor (KIR) Market Dynamics
  1. 2.1 Killer Cell Immunoglobulin Like Receptor (KIR) Industry Trends
  2. 2.2 Killer Cell Immunoglobulin Like Receptor (KIR) Industry Drivers
  3. 2.3 Killer Cell Immunoglobulin Like Receptor (KIR) Industry Opportunities and Challenges
  4. 2.4 Killer Cell Immunoglobulin Like Receptor (KIR) Industry Restraints
3 Killer Cell Immunoglobulin Like Receptor (KIR) Market by Company
  1. 3.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Revenue Ranking in 2025
  2. 3.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Revenue by Company (2021-2026)
  3. 3.3 Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Ranking (2024-2026)
  4. 3.4 Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Manufacturing Base and Headquarters
  5. 3.5 Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Product Type and Application
  6. 3.6 Global Killer Cell Immunoglobulin Like Receptor (KIR) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Killer Cell Immunoglobulin Like Receptor (KIR) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Killer Cell Immunoglobulin Like Receptor (KIR) Market by Type
  1. 4.1 Killer Cell Immunoglobulin Like Receptor (KIR) Type Introduction
  2. 4.1.1 2D
  3. 4.1.2 3D
  4. 4.1.3 Other
  5. 4.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type
  6. 4.2.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Type (2021-2032)
  8. 4.2.3 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type (2021-2032)
5 Killer Cell Immunoglobulin Like Receptor (KIR) Market by Application
  1. 5.1 Killer Cell Immunoglobulin Like Receptor (KIR) Application Introduction
  2. 5.1.1 Medical Science
  3. 5.1.2 Experiment
  4. 5.1.3 Other
  5. 5.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application
  6. 5.2.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Application (2021-2032)
  8. 5.2.3 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application (2021-2032)
6 Killer Cell Immunoglobulin Like Receptor (KIR) Regional Value Analysis
  1. 6.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032)
  7. 6.3.2 North America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032)
  10. 6.4.2 Europe Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032)
  16. 6.6.2 South America Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Country, 2025 VS 2032
7 Killer Cell Immunoglobulin Like Receptor (KIR) Country-level Value Analysis
  1. 7.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Killer Cell Immunoglobulin Like Receptor (KIR) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 R&D Systems
  2. 8.1.1 R&D Systems Company Information
  3. 8.1.2 R&D Systems Business Overview
  4. 8.1.3 R&D Systems Killer Cell Immunoglobulin Like Receptor (KIR) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 R&D Systems Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio
  6. 8.1.5 R&D Systems Recent Developments
  7. 8.2 Miltenyi Biotec
  8. 8.2.1 Miltenyi Biotec Company Information
  9. 8.2.2 Miltenyi Biotec Business Overview
  10. 8.2.3 Miltenyi Biotec Killer Cell Immunoglobulin Like Receptor (KIR) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Miltenyi Biotec Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio
  12. 8.2.5 Miltenyi Biotec Recent Developments
  13. 8.3 BioLegend
  14. 8.3.1 BioLegend Company Information
  15. 8.3.2 BioLegend Business Overview
  16. 8.3.3 BioLegend Killer Cell Immunoglobulin Like Receptor (KIR) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioLegend Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio
  18. 8.3.5 BioLegend Recent Developments
  19. 8.4 Abbexa
  20. 8.4.1 Abbexa Company Information
  21. 8.4.2 Abbexa Business Overview
  22. 8.4.3 Abbexa Killer Cell Immunoglobulin Like Receptor (KIR) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbexa Killer Cell Immunoglobulin Like Receptor (KIR) Product Portfolio
  24. 8.4.5 Abbexa Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst